Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy

Temozolomide (TMZ), an alkylating agent, is recommended as the initial treatment for high-grade glioblastoma. TMZ is widely used, but its short half-life and the frequency of tumor resistance limit its therapeutic efficacy. In the present study, the anticancer effect of vitamin D (VD) combined with...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Exp Ther Med
Main Authors: BAK, DONG-HO, KANG, SEONG HEE, CHOI, DU RI, GIL, MI NA, YU, KWANG SIK, JEONG, JI HEUN, LEE, NAM-SEOB, LEE, JE-HUN, JEONG, YOUNG-GIL, KIM, DONG KWAN, KIM, DO-KYUNG, KIM, JWA-JIN, HAN, SEUNG-YUN
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2016
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4888049/
https://ncbi.nlm.nih.gov/pubmed/27313664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3196
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares